Question · asked by 1 review
Pregabalin 300 mg or 600 mg vs placebo: Risk for at least one adverse event per patient
- Population
- adults with moderate or severe neuropathic pain
- Intervention
- Pregabalin 300 mg or 600 mg
- Comparison
- placebo
- Outcome
- Risk for at least one adverse event per patient
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pregabalin 300 mg or 600 mg vs placebo At least 1 AE · adults with moderate or severe neuropathic pain Pregabalin for neuropathic pain in adults (2019) · Cochrane Headline outcomes only | no estimate extracted | 15 studies · 3697 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.